The Cartagena Protocol on Biosafety that was adopted by governments on 29 January 2000 is the main international legally binding treaty that regulates ?the safe transfer, handling and use of living modified organisms resulting from modern biotechnology? that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health?.

It is significant as the first global treaty to attempt to contribute to the protection of biodiversity and human health in this field, and as the first treaty to operationalise the precautionary approach in decision-making relating to imports under the Protocol. As of 22 February 2005, there are 113 Parties to the Protocol.

Although the Protocol focuses on transboundary movements of GMOs, its provisions do influence national and regional biosafety policies and laws, bearing in mind that the Protocol sets minimum requirements and Parties have the right to formulate more comprehensive national laws with higher standards. This is reaffirmed in Article 2(4).

Meanwhile, work and standard setting are also taking place in other international fora, such as the Codex Alimentarius, the International Plant Protection Convention and the International Office of Epizootics, the UN Food and Agriculture Organisation and the World Health Organisation.

The linkages among trade, environment and health means that developments at the World Trade Organisation also impact on biosafety and vice versa.

A field of growing importance is the development of biological weapons as part of biodefence programmes where the adequacy of global rules and standards needs examinination.

The core issues in the Biosafety Protocol: An analysis (Chinese)

Only the core issues of the Biosafety Protocol were negotiated at Montreal in 2000. The remaining provisions were basically the same as those negotiated at the earlier talks in Cartagena in 1999. Lim Li Lin analyses and comments on these core provisions. […]

The long, winding road to a Biosafety Protocol – a South African view

At Cartagena, the South African government surprised critics by displaying a maturity and understanding of the issues and concerns facing developing countries on the question of GMOs. […]

US behind collapse of Cartagena biosafety talks

Just when the stage appeared to be set for the emergence of the world’s first international law to regulate the use, handling and cross-border transfers of GMOs in Cartegena in 1999, the US-led attacks crippled the talks. […]

EU – the South’s unreliable ally at Cartagena

Despite its declaration that it was ready to back the South to ensure an effective biosafety protocol, the European Union’s conduct at the Cartagena negotiations clearly revealed that it was quite prepared to abandon the South and the cause of biosafety. […]

The Cartagena Protocol – a battle over trade or biosafety?

The negotiations at Cartagena in 1999 were doomed to failure, argues Lavanya Rajamani, given the backdrop in which they were conducted. The real battle was over trade, not biosafety. […]

Elements of a Biosafety Protocol: The Position of the South

At Cartagena in 1999 during the negotiation on the Biosafety protocol, the South put forward the basic constituents of a strong Biosafety Protocol. Gurdial Singh Nijar, sets out and discusses these key elements. […]